2018
Tylichová, Zuzana; Slavík, Josef; Ciganek, Miroslav; Ovesná, Petra; Krčmář, Pavel; Straková, Nicol; Machala, Miroslav; Kozubík, Alois; Hofmanová, Jiřina; Vondráček, Jan
Butyrate and docosahexaenoic acid interact in alterations of specific lipid classes in differentiating colon cancer cells. Journal Article
In: Journal of cellular biochemistry, vol. 119, no. 6, pp. 4664–4679, 2018, ISSN: 1097-4644 0730-2312, (Place: United States).
Abstract | Links | BibTeX | Tags: Apoptosis/*drug effects, Butyrate, Butyrates/*pharmacology, Cell Differentiation/*drug effects, Ceramides, Colon cancer, Colonic Neoplasms/*metabolism/pathology, Docosahexaenoic acid, Docosahexaenoic Acids/*pharmacology, HCT116 Cells, Humans, lipid analyses, Lipid Metabolism/*drug effects, Membrane Lipids/classification/*metabolism, Phospholipids
@article{tylichova_butyrate_2018,
title = {Butyrate and docosahexaenoic acid interact in alterations of specific lipid classes in differentiating colon cancer cells.},
author = {Zuzana Tylichová and Josef Slavík and Miroslav Ciganek and Petra Ovesná and Pavel Krčmář and Nicol Straková and Miroslav Machala and Alois Kozubík and Jiřina Hofmanová and Jan Vondráček},
doi = {10.1002/jcb.26641},
issn = {1097-4644 0730-2312},
year = {2018},
date = {2018-06-01},
journal = {Journal of cellular biochemistry},
volume = {119},
number = {6},
pages = {4664–4679},
abstract = {Docosahexaenoic acid (DHA) and sodium butyrate (NaBt) exhibit a number of interactive effects on colon cancer cell growth, differentiation, or apoptosis; however, the molecular mechanisms responsible for these interactions and their impact on cellular lipidome are still not fully clear. Here, we show that both dietary agents together induce dynamic alterations of lipid metabolism, specific cellular lipid classes, and fatty acid composition. In HT-29 cell line, a model of differentiating colon carcinoma cells, NaBt supported incorporation of free DHA into non-polar lipids and their accumulation in cytoplasmic lipid droplets. DHA itself was not incorporated into sphingolipids; however, it significantly altered representation of individual ceramide (Cer) classes, in particular in combination with NaBt (DHA/NaBt). We observed altered expression of enzymes involved in Cer metabolism in cells treated with NaBt or DHA/NaBt, and exogenous Cer 16:0 was found to promote induction of apoptosis in differentiating HT-29 cells. NaBt, together with DHA, increased n-3 fatty acid synthesis and attenuated metabolism of monounsaturated fatty acids. Finally, DHA and/or NaBt altered expression of proteins involved in synthesis of fatty acids, including elongase 5, stearoyl CoA desaturase 1, or fatty acid synthase, with NaBt increasing expression of caveolin-1 and CD36 transporter, which may further promote DHA incorporation and its impact on cellular lipidome. In conclusion, our results indicate that interactions of DHA and NaBt exert complex changes in cellular lipidome, which may contribute to the alterations of colon cancer cell differentiation/apoptotic responses. The present data extend our knowledge about the nature of interactive effects of dietary fatty acids.},
note = {Place: United States},
keywords = {Apoptosis/*drug effects, Butyrate, Butyrates/*pharmacology, Cell Differentiation/*drug effects, Ceramides, Colon cancer, Colonic Neoplasms/*metabolism/pathology, Docosahexaenoic acid, Docosahexaenoic Acids/*pharmacology, HCT116 Cells, Humans, lipid analyses, Lipid Metabolism/*drug effects, Membrane Lipids/classification/*metabolism, Phospholipids},
pubstate = {published},
tppubtype = {article}
}